Patents for A61P 35 - Antineoplastic agents (221,099)
10/2014
10/08/2014EP2785689A1 Amorphous ezatiostat ansolvate
10/08/2014EP2785683A1 Inkt cell modulators and methods of using the same
10/08/2014EP2785635A1 Mmp-targeted therapeutic and/or diagnostic nanocarriers
10/08/2014EP2785382A1 Multivalent antibody complexes targeting igf-1r show potent toxicity against solid tumors
10/08/2014EP2785361A1 Immunogenic treatment of cancer
10/08/2014EP2785357A2 Pharmaceutical compositions of sodium ion and calcium ion and methods for treating cancer, tumor and non-malignancy
10/08/2014EP2785355A1 Targeting micrornas mir-409-5p, mir-379 and mir-154* to treat prostate cancer bone metastasis and drug resistant lung cancer
10/08/2014EP2785349A1 Combination treatment of cancer
10/08/2014EP2785325A1 Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, a solid form thereof and methods of their use
10/07/2014US8853384 RNA interference mediating small RNA molecules
10/07/2014US8853270 Substituted stilbenes and their reactions
10/07/2014US8853217 Compounds useful as inhibitors of ATR kinase
10/07/2014US8853216 Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor
10/07/2014US8853211 Pyridazinone derivatives
10/07/2014US8853207 Heterocyclic pyrazole compounds, method for preparing the same and use thereof
10/07/2014US8853202 Modulators of CXCR7
10/07/2014US8853199 Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
10/07/2014US8853193 Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions
10/07/2014US8853187 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
10/07/2014US8853163 Methods for increasing vascular density and maintaining viability of microvascular endothelial cells using trk receptor ligands
10/07/2014US8853154 Fibronectin based scaffold domain proteins that bind to myostatin
10/07/2014US8852612 Universal carrier for targeting molecules to Gb3 receptor expressing cells
10/07/2014US8852599 Immunoconjugates, compositions for making them, and methods of making and use
10/07/2014US8852590 Compositions and methods for treating cancer
10/07/2014US8852551 Methods to impair hematologic cancer progenitor cells and compounds related thereto
10/07/2014US8852550 Chelator conjugates
10/03/2014CA2847971A1 Stilbenoid compounds as inhibitors for squamous carcinoma and hepatoma and uses thereof
10/02/2014WO2014160873A1 Benzimidazolone derivatives as bromodomain inhibitors
10/02/2014WO2014160723A1 Compounds for the treatment of glioma
10/02/2014WO2014160698A1 SOLID FORMS COMPRISING 4-AMINO-I-β-D-RIBOFURANOSYL-1,3,5-TRIAZIN-2(1H)-ONE AND A COFORMER, COMPOSITIONS AND METHODS OF USE THEREOF
10/02/2014WO2014160508A1 Methods and compositions for treating cancer and inflammatory diseases
10/02/2014WO2014160430A1 Small molecule lrrk2 and erk5 inhibitors
10/02/2014WO2014160401A1 3-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancer
10/02/2014WO2014160360A1 Tubulysin compounds and conjugates thereof
10/02/2014WO2014160339A1 Compounds for treating inflammatory and hyperproliferative diseases
10/02/2014WO2014160336A1 METHODS OF ADMINISTERING IgG1 ANTIBODIES AND METHODS OF SUPPRESSING ANGIOGENESIS
10/02/2014WO2014160318A1 Endogenous vaccine for cancer and infectious diseases
10/02/2014WO2014160183A1 Methods for modulating chemotherapeutic cytotoxicity
10/02/2014WO2014160130A1 Combination therapy with 7-benzyl-10-(2-methylbenzyl)-2,6,7,8,9,10-hexahydroimidazo[1,2-a]pyrido[4,3-d]pyrimidin-5(3h)-one
10/02/2014WO2014160034A1 Aldehyde dehydrogenase-1 modulators and methods of use thereof
10/02/2014WO2014160017A1 Pyridine cdk9 kinase inhibitors
10/02/2014WO2014159999A1 Cdk9 kinase inhibitors
10/02/2014WO2014159923A1 Enhancement of vaccines
10/02/2014WO2014159920A1 A device and method for the detection and diagnosis of aggressive and metastatic cancer and cancer stem cells employing podocalyxin and tra biomarkers
10/02/2014WO2014159915A1 Her3 specific monoclonal antibodies for diagnostic and therapeutic use
10/02/2014WO2014159911A1 Compositions comprising anti-cd38 antibodies and carfilzomib
10/02/2014WO2014159837A1 Methods and compositions for inhibition of bromodomain-containing proteins
10/02/2014WO2014159835A1 Anti-b7-h4 antibodies and immunoconjugates
10/02/2014WO2014159774A1 Custirsen treatment with reduced toxicity
10/02/2014WO2014159690A1 Dna-pk inhibitors
10/02/2014WO2014159580A1 Met-binding agents and uses thereof
10/02/2014WO2014159500A1 Regulation of cancer using natural compounds and/or diet
10/02/2014WO2014159353A1 Solid state forms of vemurafenib hydrochloride
10/02/2014WO2014159171A1 Methods of treating lung cancer
10/02/2014WO2014159010A1 Human antibodies to grem 1
10/02/2014WO2014158875A1 Novel therapy for prostate carcinoma
10/02/2014WO2014158811A1 Newcastle disease viruses and uses thereof
10/02/2014WO2014158528A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
10/02/2014WO2014157966A1 Pharmaceutical composition for preventing or treating ovary granulosa cell tumors containing glycogen synthase kinase-3 beta inhibitor as active ingredient, and functional health food composition
10/02/2014WO2014157965A1 Composition for treatment or metastasis suppression of cancers which includes p34 expression inhibitor or activity inhibitor as active ingredient
10/02/2014WO2014157740A1 Pyrazole derivative
10/02/2014WO2014157704A1 Conjugate vaccine using trimming function of erap1
10/02/2014WO2014157692A1 Wt1-antigen peptide conjugate vaccine
10/02/2014WO2014157687A1 1,2,4-triazine-6-carboxamide derivative with acetamide group
10/02/2014WO2014157595A1 Novel polypeptides and utilization thereof
10/02/2014WO2014157444A1 Low-dose antitumor agent including irinotecan hydrochloride hydrate
10/02/2014WO2014157443A1 Antitumor agent including irinotecan hydrochloride hydrate
10/02/2014WO2014157380A1 Therapeutic agent for wounds or fibrosis
10/02/2014WO2014157229A1 Tace peptide epitope, antihuman tace protein antibody and hybridoma producing antibody
10/02/2014WO2014157158A1 Phenyl derivative
10/02/2014WO2014157107A1 Polypeptide having sialylated sugar chains attached thereto
10/02/2014WO2014156958A1 Nano-capsule, composition, polynucleotide, recombinant vector, and transformant
10/02/2014WO2014155376A1 Methods of treating myeloid leukemia
10/02/2014WO2014155301A1 Substituted bicyclic compounds as inhibitors of ezh2
10/02/2014WO2014155146A1 Stable nanocomposition comprising paclitaxel, process for the preparation thereof, its use and pharmaceutical compositions containing it
10/02/2014WO2014155145A1 Stable nanocomposition comprising epirubicin, process for the preparation thereof, its use and pharmaceutical compositions containing it
10/02/2014WO2014155144A1 Stable nanocomposition comprising docetaxel, process for the preparation thereof, its use and pharmaceutical compositions containing it
10/02/2014WO2014155142A1 Stable nanocomposition comprising doxorubicin, process for the preparation thereof, its use and pharmaceutical compositions containing it
10/02/2014WO2014154921A1 Method for the synthesis of homologous compounds of azanucleosides
10/02/2014WO2014154905A1 A cancer vaccine for dogs
10/02/2014WO2014154904A1 A cancer vaccine for cats
10/02/2014WO2014154843A1 Modified tgf-beta2 oligonucleotides
10/02/2014WO2014154762A1 Dihydroquinazolinone analogues as brd4 inhibitors
10/02/2014WO2014154760A1 Indolinone analogues as brd4 inhibitors
10/02/2014WO2014154723A1 Novel pyrrole derivatives for the treatment of cancer
10/02/2014WO2014154179A1 2β,3α,5α-TRIHYDROXY-ANDROST-6-ONE AND PREPARATION METHODS AND USE THEREOF
10/02/2014WO2014154156A1 Traditional chinese medicine composition with anticancer effect, and preparation method therefor and application thereof
10/02/2014WO2014154117A1 Isothiocyanate, preparation method therefor, and use against cancer
10/02/2014WO2014154026A1 PI3K AND/OR mTOR INHIBITOR PRODRUG
10/02/2014WO2014153636A1 Method for improving the efficacy of a survivin vaccine in the treatment of cancer
10/02/2014US20140296128 Materials and methods for treatment of cancer and identification of anti-cancer compounds
10/02/2014US20140294842 Assays, Methods and Means
10/01/2014EP2784093A1 Polyethylene glycol-modified integrin blocker hm-3 and use thereof
10/01/2014EP2784091A1 Bispecific anti-cMet/anti-Her2 antibodies
10/01/2014EP2784078A1 Benzoxepin pi3k inhibitor compounds and methods of use
10/01/2014EP2784076A1 Dimeric SMAC mimetics
10/01/2014EP2784061A1 Acyl-hydrazone and oxadiazole compounds, pharmaceutical compositions containing the same and uses thereof
10/01/2014EP2783700A1 Cancer stem cell-targeted cancer therapy
10/01/2014EP2783686A1 Combination of a rapamycin derivative and letrozole for treating breast cancer
10/01/2014EP2783679A1 Drug carrier with chelating composite micell and use thereof
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 2211